Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases of Henan Province, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Co-Innovation Centre of Henan Province for New Drug R&D and Preclinical Safety, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
China National Tobacco Quality Supervision and Test Centre, Zhengzhou, China.
J Chromatogr A. 2022 Mar 29;1667:462891. doi: 10.1016/j.chroma.2022.462891. Epub 2022 Feb 10.
In this work, a stable isotope labelling-flow injection analysis-tandem mass spectrometry (SIL-FIA-MS/MS) with simultaneous monitoring [M+H] and [M+Cl] method was developed for very specific and high throughput screening of anabolic-androgenic steroids (AAS) illegally added to healthy foods. Initially, a simple centrifugation step was carried out for liquid samples, and for solid samples, a solid-liquid extraction step was conducted. Afterwards, batch chemical derivatization was carried out. After adding a certain amount of C-3-NPH labelled AAS standards as the internal standards, it can be directly transferred for FIA-MS/MS analysis based on the no MS response characteristics of 3-NPH. The 3-NPH labelled AAS showed dual-polarity property, observing chloride adduct ion ([M+Cl]) in negative ion mode and proton adduct ion ([M+H]) in positive ion mode. The average time cost for pretreatment of each sample was less than 1 min by carrying out batch processing. The subsequent FIA-MS/MS detection enabled rapid and high throughput detection. The addition of C-3-NPH-labelled AAS as internal standards can correct the matrix effect to achieve accurate quantitative analysis. The detection sensitivity was also improved by 2-5 folds after 3-NPH labelling. The limits of detection (LODs) in positive MRM mode were in ranges of 0.1-0.3 ng/mL. The validated method with simultaneous monitoring [M+H] and [M+Cl] was validated in the range of 6.0-1000 ng/mL with the linear coefficient (R) greater than 0.997. Satisfactory recoveries were found to be in ranges of 93.0-108.7%. The intra-day and inter-day RSDs were in the range of 3.5-9.9% and 5.1-14.1%, respectively. No changes in detection sensitivity of the mass spectrometry and no carry-over effects were found after numerous consecutive injections of AAS derivates. Compared with previously reported methods, the proposed method proved accurate, very specific, high throughput with good sensitivity.
本工作建立了一种稳定同位素标记-流动注射分析-串联质谱(SIL-FIA-MS/MS)联用方法,可同时监测[M+H]+和[M+Cl]-,用于对添加到健康食品中的合成代谢雄激素类固醇(AAS)进行特异性强、高通量的筛选。首先,对液体样品进行简单的离心步骤,对固体样品进行固液萃取步骤。然后,进行批量化学衍生化。加入一定量的 C-3-NPH 标记的 AAS 标准品作为内标后,可根据 3-NPH 无 MS 响应的特点直接进行 FIA-MS/MS 分析。3-NPH 标记的 AAS 具有双极性,在负离子模式下观察到氯加合物离子([M+Cl]-),在正离子模式下观察到质子加合物离子([M+H]+)。通过批量处理,每个样品的预处理平均时间不到 1 分钟。随后的 FIA-MS/MS 检测实现了快速、高通量的检测。加入 C-3-NPH 标记的 AAS 作为内标可以校正基质效应,实现准确的定量分析。3-NPH 标记后,检测灵敏度提高了 2-5 倍。正 MRM 模式下的检测限(LOD)在 0.1-0.3 ng/mL 范围内。同时监测[M+H]+和[M+Cl]-的验证方法在 6.0-1000 ng/mL 范围内具有大于 0.997 的线性系数(R)。发现回收率在 93.0-108.7%范围内。日内和日间 RSD 分别在 3.5-9.9%和 5.1-14.1%范围内。大量连续注射 AAS 衍生物后,质谱的检测灵敏度没有变化,也没有出现拖尾效应。与之前报道的方法相比,该方法具有准确性高、特异性强、高通量、灵敏度好的特点。